Accordingly, the current study set out to explore the clinical roles of serum miR-124-3p/ANGPTL2 in PCOS, and our findings revealed that high expression of ANGPTL2 and low expression of miR-124-3p could assist the diagnosis of obese and nonobese PCOS. This evidence concerns the gene ANGPTL2 and polycystic ovary syndrome.